News
Register to attend a free NIH webinar to learn about a new non-opioid small molecule for treating opioid use and substance use disorders by selectively targeting the dopamine D3 receptor. Dr. Amy Newman and her team at the National Institutes of Health’s National Institute on Drug Abuse (NIDA)
The National Institute for Allergy and Infectious Diseases (NIAID) has been recognized by the FLC for their impact on the public through their technology transfer work. NIH was awarded six of the 33 awards across nine different technology transfer categories, in addition to a COVID-19 Response award
The Association of University Technology Managers (AUTM) Annual Meeting is a chance for technology transfer professionals to get together – virtually this year – and hear from world-class speakers in over 60 educational workshops and roundtable discussions. NIH’s own Bruce Goldstein and Karen Rogers
The Centers for Disease Control and Prevention (CDC) and the National Institute for Allergy and Infectious Diseases (NIAID) have been rewarded for their partnership from the 2021 Federal Laboratory Consortium (FLC) awards. NIH was awarded six of the 33 awards across nine different technology